Novo Integrated Sciences Inc (NVOS)
0.6089
+0.04
(+7.37%)
USD |
NASDAQ |
May 02, 14:22
Novo Integrated Sciences Debt to Equity Ratio: 0.1478 for Feb. 29, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| February 29, 2024 | 0.1478 |
| November 30, 2023 | 0.1116 |
| August 31, 2023 | 0.0947 |
| May 31, 2023 | 0.0884 |
| February 28, 2023 | 0.0719 |
| November 30, 2022 | 0.3779 |
| August 31, 2022 | 0.4576 |
| May 31, 2022 | 0.4278 |
| February 28, 2022 | 0.4081 |
| November 30, 2021 | 0.2854 |
| August 31, 2021 | 0.2526 |
| May 31, 2021 | 0.0315 |
| February 28, 2021 | 0.0519 |
| November 30, 2020 | 0.0356 |
| Date | Value |
|---|---|
| August 31, 2020 | 0.0528 |
| May 31, 2020 | 0.0406 |
| February 29, 2020 | 0.0393 |
| November 30, 2019 | 0.0471 |
| August 31, 2019 | 0.047 |
| May 31, 2019 | 0.0613 |
| February 28, 2019 | 0.0642 |
| November 30, 2018 | 2.870 |
| August 31, 2018 | 7.976 |
| May 31, 2018 | 5.286 |
| February 28, 2018 | 4.386 |
| November 30, 2017 | -1.234 |
| August 31, 2017 | -1.299 |
| May 31, 2017 | -1.136 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.0315
Minimum
May 2021
0.4576
Maximum
Aug 2022
0.1565
Average
0.0801
Median
Debt to Equity Ratio Benchmarks
| American Shared Hospital Services | 0.7773 |
| Astrana Health Inc | 0.4533 |
| Cryo-Cell International Inc | -1.019 |
| P3 Health Partners Inc | 0.7621 |
| Biote Corp | -3.840 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 34.95M |
| Total Liabilities (Quarterly) | 13.06M |
| Shareholders Equity (Quarterly) | 22.19M |
| Current Ratio | 0.504 |
| Net Debt Paydown Yield | 8.28% |